Alpelisib for PIK3CA-Mutated Advanced Breast Cancer. Reply
N Engl J Med
.
2019 Aug 15;381(7):687.
doi: 10.1056/NEJMc1907856.
Authors
Fabrice André
1
,
David Mills
2
,
Tetiana Taran
2
Affiliations
1
Gustave Roussy Cancer Center, Villejuif, France fabrice.andre@gustaveroussy.fr.
2
Novartis Pharmaceuticals, East Hanover, NJ.
PMID:
31412193
DOI:
10.1056/NEJMc1907856
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms*
Class I Phosphatidylinositol 3-Kinases
Humans
Thiazoles
Substances
Thiazoles
Alpelisib
Class I Phosphatidylinositol 3-Kinases
PIK3CA protein, human